{
  "company_id": "jnj",
  "company_name": "Johnson & Johnson",
  "generated_at": "2026-02-05T09:49:26Z",
  "kpis": {
    "assets_total": 45,
    "assets_with_trials": 19,
    "trials_total": 267
  },
  "top_assets": [
    {
      "asset_id": 64,
      "asset_name": "Azacitidine",
      "highest_stage": "Registration",
      "linked_trials_count": 4,
      "indications": [
        {
          "indication": "Cancer (ATLAS) intravesical delivery system) Invasive Bladder Cancer BCG",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Cancer (ATLAS) intravesical delivery system) Invasive Bladder Cancer BCG",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Cancer (ATLAS) intravesical delivery system) Invasive Bladder Cancer BCG (ORIGAMI-2) Multiple Myeloma CD38 exposed with DR (MajesTEC-7)",
          "stage": "Registration",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 45,
      "asset_name": "ypertension75mg",
      "highest_stage": "Registration",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "pipeline is based on the current status of these this information. *AC Immune ACI-35.030. of rilpivirine and cabotegravir: ViiV Healthcare; Tau Immunotherapy: AC Immune SA; Biotech; AKEEGA: TESARO, an oncology- iPSC-derived chimeric antigen receptor",
          "stage": "Registration",
          "therapeutic_area": null
        },
        {
          "indication": "pipeline is based on the current status of these this information. *AC Immune ACI-35.030. of rilpivirine and cabotegravir: ViiV Healthcare; Tau Immunotherapy: AC Immune SA; Biotech; AKEEGA: TESARO, an oncology- iPSC-derived chimeric antigen receptor",
          "stage": "Registration",
          "therapeutic_area": null
        },
        {
          "indication": "pipeline is based on the current status of these this information. *AC Immune ACI-35.030. of rilpivirine and cabotegravir: ViiV Healthcare; Tau Immunotherapy: AC Immune SA; Biotech; AKEEGA: TESARO, an oncology- iPSC-derived chimeric antigen receptor",
          "stage": "Registration",
          "therapeutic_area": null
        }
      ]
    },
    {
      "asset_id": 69,
      "asset_name": "PROTOSTAR",
      "highest_stage": "Registration",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Arthritis Hemolytic Anemia (ENERGY) Alloimmune Thrombocytopenia",
          "stage": "Registration",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Arthritis Hemolytic Anemia (ENERGY) Alloimmune Thrombocytopenia",
          "stage": "Registration",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 12,
      "asset_name": "TALVEY + TECVAYLI",
      "highest_stage": "Phase 3",
      "linked_trials_count": 41,
      "indications": [
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory (MonumenTAL-6)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory (MonumenTAL-6)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 10,
      "asset_name": "ERLEADA",
      "highest_stage": "Phase 3",
      "linked_trials_count": 27,
      "indications": [
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 5,
      "asset_name": "RYBREVANT",
      "highest_stage": "Phase 3",
      "linked_trials_count": 21,
      "indications": [
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Colorectal Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Frontline Non Small chemotherapy (PAPILLON) Bleximenib Newly Diagnosed AML, with Venetoclax and ERLEADA (apalutamide) ASCT Localized Prostate",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 25,
      "asset_name": "TREMFYA",
      "highest_stage": "Phase 3",
      "linked_trials_count": 8,
      "indications": [
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Ulcerative Colitis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Ulcerative",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Psoriasis",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Pediatric Juvenile Psoriatic",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 72,
      "asset_name": "INLEXZO",
      "highest_stage": "Phase 3",
      "linked_trials_count": 6,
      "indications": [
        {
          "indication": "High Risk High Risk Non Muscle Experienced (SunRISe-5) RYBREVANT (amivantamab) Colorectal Cancer TALVEY + TECVAYLI Relapsed Refractory (MonumenTAL-6) TALVEY (talquetamab) TIE NDMM in combination",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 57,
      "asset_name": "nipocalimab",
      "highest_stage": "Phase 3",
      "linked_trials_count": 5,
      "indications": [
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Hemolytic Disease",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Warm Autoimmune",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Fetal and Neonatal",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Chronic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 19,
      "asset_name": "bleximenib",
      "highest_stage": "Phase 3",
      "linked_trials_count": 5,
      "indications": [
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Relapsed Refractory 1)",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 37,
      "asset_name": "SPRAVATO",
      "highest_stage": "Phase 3",
      "linked_trials_count": 3,
      "indications": [
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 26,
      "asset_name": "icotrokinra",
      "highest_stage": "Phase 3",
      "linked_trials_count": 2,
      "indications": [
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease (ICONIC-CD)",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease (ICONIC-CD)",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 22,
      "asset_name": "JNJ-7446",
      "highest_stage": "Phase 3",
      "linked_trials_count": 2,
      "indications": [
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lung Cancer",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 43,
      "asset_name": "SIRTURO",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "L e p r o s y under review by regulatory bodies. Inclusion in the & Johnson assumes no obligation to update Long acting HIV injectible treatment regimen",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies. Inclusion in the & Johnson assumes no obligation to update Long acting HIV injectible treatment regimen",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies. Inclusion in the & Johnson assumes no obligation to update Long acting HIV injectible treatment regimen",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        },
        {
          "indication": "L e p r o s y under review by regulatory bodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        }
      ]
    },
    {
      "asset_id": 75,
      "asset_name": "PulmonaryArterialH",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "SIRTUROLeprosyunderreviewbyregulatorybodies.",
          "stage": "Phase 3",
          "therapeutic_area": null
        }
      ]
    },
    {
      "asset_id": 74,
      "asset_name": "JNJ-8543",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 28,
      "asset_name": "JNJ-4804 Co-antibody",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Psoriatic Arthritis nipocalimab\u200b Systemic Lupus",
          "stage": "Phase 1",
          "therapeutic_area": "Immunology"
        },
        {
          "indication": "Crohn's Disease nipocalimab\u200b Idiopathic Inflammatory",
          "stage": "Phase 3",
          "therapeutic_area": "Immunology"
        }
      ]
    },
    {
      "asset_id": 21,
      "asset_name": "JNJ-4681",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Hematological Malignancies",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 66,
      "asset_name": "JNJ-3413",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Lymphoma",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lymphoma",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Lymphoma",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 20,
      "asset_name": "JNJ-2175",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Solid Tumors",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 60,
      "asset_name": "JNJ-1887 sCD59",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Geographic Atrophy SPRAVATO (esketamine) Major Depressive Disorder Pediatrics",
          "stage": "Phase 3",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 1,
      "asset_name": "INLEXZO (gemcitabine",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive (SunRISe-3)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Non Muscle Invasive (SunRISe-3)",
          "stage": "Phase 1",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "High Risk High Risk Non Muscle",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 9,
      "asset_name": "Bleximenib",
      "highest_stage": "Phase 3",
      "linked_trials_count": 0,
      "indications": [
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Newly Diagnosed AML, with Venetoclax and",
          "stage": "Phase 3",
          "therapeutic_area": "Oncology"
        }
      ]
    },
    {
      "asset_id": 59,
      "asset_name": "Gravis",
      "highest_stage": "Phase 2",
      "linked_trials_count": 43,
      "indications": [
        {
          "indication": "Indications for Major Depressive Disorder",
          "stage": "Phase 2",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Indications for Major Depressive Disorder",
          "stage": "Phase 2",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Indications for Major Depressive Disorder",
          "stage": "Phase 2",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Indications for Major Depressive Disorder",
          "stage": "Phase 2",
          "therapeutic_area": "Neuroscience"
        },
        {
          "indication": "Indications for Major Depressive Disorder",
          "stage": "Phase 2",
          "therapeutic_area": "Neuroscience"
        }
      ]
    },
    {
      "asset_id": 63,
      "asset_name": "amivantamab",
      "highest_stage": "Phase 2",
      "linked_trials_count": 27,
      "indications": [
        {
          "indication": "Cancer (ORIGAMI-5)",
          "stage": "Phase 2",
          "therapeutic_area": "Oncology"
        },
        {
          "indication": "Cancer (ORIGAMI-5)",
          "stage": "Phase 2",
          "therapeutic_area": "Oncology"
        }
      ]
    }
  ],
  "recent_changes": [
    {
      "event_type": "trials_ingested",
      "created_at": "2026-02-05 09:49:20.674730",
      "occurred_at": "2026-02-05 09:49:20.674730",
      "payload": {
        "trials_seen": 197,
        "inserted": 4,
        "updated": 193,
        "status_changed": 0,
        "bad_aliases": 0
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:19.235419",
      "occurred_at": "2026-02-05 09:49:19.235419",
      "payload": {
        "query_alias": "Subcutaneous Induction",
        "added_alias": "Velcade",
        "assets": [
          67
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:19.232342",
      "occurred_at": "2026-02-05 09:49:19.232342",
      "payload": {
        "query_alias": "Subcutaneous Induction",
        "added_alias": "Bortezomib",
        "assets": [
          67
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:19.229300",
      "occurred_at": "2026-02-05 09:49:19.229300",
      "payload": {
        "query_alias": "Subcutaneous Induction",
        "added_alias": "Lenalidomide",
        "assets": [
          67
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:19.226223",
      "occurred_at": "2026-02-05 09:49:19.226223",
      "payload": {
        "query_alias": "Subcutaneous Induction",
        "added_alias": "Daratumumab",
        "assets": [
          67
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:19.223199",
      "occurred_at": "2026-02-05 09:49:19.223199",
      "payload": {
        "query_alias": "Subcutaneous Induction",
        "added_alias": "Dexamethasone",
        "assets": [
          67
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:18.918582",
      "occurred_at": "2026-02-05 09:49:18.918582",
      "payload": {
        "nct_id": "NCT06189833",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:18.495759",
      "occurred_at": "2026-02-05 09:49:18.495759",
      "payload": {
        "nct_id": "NCT03004287",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:10.686240",
      "occurred_at": "2026-02-05 09:49:10.686240",
      "payload": {
        "query_alias": "gemcitabine",
        "added_alias": "Cisplatin",
        "assets": [
          72
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:10.683545",
      "occurred_at": "2026-02-05 09:49:10.683545",
      "payload": {
        "query_alias": "gemcitabine",
        "added_alias": "JNJ-63723283",
        "assets": [
          72
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:10.680975",
      "occurred_at": "2026-02-05 09:49:10.680975",
      "payload": {
        "query_alias": "gemcitabine",
        "added_alias": "Cetrelimab",
        "assets": [
          72
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:10.678353",
      "occurred_at": "2026-02-05 09:49:10.678353",
      "payload": {
        "query_alias": "gemcitabine",
        "added_alias": "JNJ-17000139",
        "assets": [
          72
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:10.675433",
      "occurred_at": "2026-02-05 09:49:10.675433",
      "payload": {
        "query_alias": "gemcitabine",
        "added_alias": "Gemcitabine",
        "assets": [
          72
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:10.673428",
      "occurred_at": "2026-02-05 09:49:10.673428",
      "payload": {
        "query_alias": "gemcitabine",
        "added_alias": "JNJ-42756493",
        "assets": [
          72
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:06.908569",
      "occurred_at": "2026-02-05 09:49:06.908569",
      "payload": {
        "nct_id": "NCT02436707",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-05 09:49:06.897443",
      "occurred_at": "2026-02-05 09:49:06.897443",
      "payload": {
        "nct_id": "NCT02436707",
        "title": "A Multi-Stage Randomized Phase II Study of Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma"
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:06.890749",
      "occurred_at": "2026-02-05 09:49:06.890749",
      "payload": {
        "nct_id": "NCT06211764",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-05 09:49:06.881628",
      "occurred_at": "2026-02-05 09:49:06.881628",
      "payload": {
        "nct_id": "NCT06211764",
        "title": "A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator's Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Gu\u00e9rin (BCG) and Recurred With High-risk Non-muscle-invasive Bladder Cancer (HR-NMIBC) and Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy"
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:06.873779",
      "occurred_at": "2026-02-05 09:49:06.873779",
      "payload": {
        "nct_id": "NCT04658862",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-05 09:49:06.863929",
      "occurred_at": "2026-02-05 09:49:06.863929",
      "payload": {
        "nct_id": "NCT04658862",
        "title": "A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder Who Are Not Receiving Radical Cystectomy"
      }
    },
    {
      "event_type": "trial_added",
      "created_at": "2026-02-05 09:49:06.848361",
      "occurred_at": "2026-02-05 09:49:06.848361",
      "payload": {
        "nct_id": "NCT04640623",
        "title": "Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy"
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:06.838949",
      "occurred_at": "2026-02-05 09:49:06.838949",
      "payload": {
        "nct_id": "NCT06919965",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:06.354164",
      "occurred_at": "2026-02-05 09:49:06.354164",
      "payload": {
        "nct_id": "NCT06319820",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:06.134791",
      "occurred_at": "2026-02-05 09:49:06.134791",
      "payload": {
        "query_alias": "Azacitidine",
        "added_alias": "JNJ-74494550",
        "assets": [
          9,
          19,
          64
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:06.129781",
      "occurred_at": "2026-02-05 09:49:06.129781",
      "payload": {
        "query_alias": "Azacitidine",
        "added_alias": "Cusatuzumab",
        "assets": [
          9,
          19,
          64
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:06.123773",
      "occurred_at": "2026-02-05 09:49:06.123773",
      "payload": {
        "query_alias": "Azacitidine",
        "added_alias": "Azacitidine",
        "assets": [
          9,
          19,
          64
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:05.016359",
      "occurred_at": "2026-02-05 09:49:05.016359",
      "payload": {
        "nct_id": "NCT04150887",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:04.579816",
      "occurred_at": "2026-02-05 09:49:04.579816",
      "payload": {
        "nct_id": "NCT04023526",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:03.961407",
      "occurred_at": "2026-02-05 09:49:03.961407",
      "payload": {
        "query_alias": "nipocalimab",
        "added_alias": "JNJ-86507083",
        "assets": [
          57,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:03.958357",
      "occurred_at": "2026-02-05 09:49:03.958357",
      "payload": {
        "query_alias": "nipocalimab",
        "added_alias": "Placebo",
        "assets": [
          57,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:03.955420",
      "occurred_at": "2026-02-05 09:49:03.955420",
      "payload": {
        "query_alias": "nipocalimab",
        "added_alias": "JNJ-80202135",
        "assets": [
          57,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:03.952262",
      "occurred_at": "2026-02-05 09:49:03.952262",
      "payload": {
        "query_alias": "nipocalimab",
        "added_alias": "Nipocalimab",
        "assets": [
          57,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:03.950129",
      "occurred_at": "2026-02-05 09:49:03.950129",
      "payload": {
        "query_alias": "nipocalimab",
        "added_alias": "M281",
        "assets": [
          57,
          59
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:03.646078",
      "occurred_at": "2026-02-05 09:49:03.646078",
      "payload": {
        "nct_id": "NCT04883619",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:03.634152",
      "occurred_at": "2026-02-05 09:49:03.634152",
      "payload": {
        "nct_id": "NCT06533098",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:03.622424",
      "occurred_at": "2026-02-05 09:49:03.622424",
      "payload": {
        "nct_id": "NCT06449651",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:03.611107",
      "occurred_at": "2026-02-05 09:49:03.611107",
      "payload": {
        "nct_id": "NCT05379634",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:03.598847",
      "occurred_at": "2026-02-05 09:49:03.598847",
      "payload": {
        "nct_id": "NCT05327114",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:03.586625",
      "occurred_at": "2026-02-05 09:49:03.586625",
      "payload": {
        "nct_id": "NCT04119050",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:02.810296",
      "occurred_at": "2026-02-05 09:49:02.810296",
      "payload": {
        "query_alias": "icotrokinra",
        "added_alias": "Placebo",
        "assets": [
          26,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:02.807202",
      "occurred_at": "2026-02-05 09:49:02.807202",
      "payload": {
        "query_alias": "icotrokinra",
        "added_alias": "JNJ-77242113",
        "assets": [
          26,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:02.803553",
      "occurred_at": "2026-02-05 09:49:02.803553",
      "payload": {
        "query_alias": "icotrokinra",
        "added_alias": "Icotrokinra",
        "assets": [
          26,
          59
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:02.500949",
      "occurred_at": "2026-02-05 09:49:02.500949",
      "payload": {
        "nct_id": "NCT06878404",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:02.487329",
      "occurred_at": "2026-02-05 09:49:02.487329",
      "payload": {
        "nct_id": "NCT06807424",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.567906",
      "occurred_at": "2026-02-05 09:49:01.567906",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Levoleucovorin",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.563892",
      "occurred_at": "2026-02-05 09:49:01.563892",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "5-fluorouracil",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.560031",
      "occurred_at": "2026-02-05 09:49:01.560031",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Erbitux",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.556310",
      "occurred_at": "2026-02-05 09:49:01.556310",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Cetuximab",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.552380",
      "occurred_at": "2026-02-05 09:49:01.552380",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Co-Formulated",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.548549",
      "occurred_at": "2026-02-05 09:49:01.548549",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "YH25448",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.544686",
      "occurred_at": "2026-02-05 09:49:01.544686",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Carboplatin",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.540707",
      "occurred_at": "2026-02-05 09:49:01.540707",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Pemetrexed",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.536197",
      "occurred_at": "2026-02-05 09:49:01.536197",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "YH-25448",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.531051",
      "occurred_at": "2026-02-05 09:49:01.531051",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "JNJ-73841937",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.526978",
      "occurred_at": "2026-02-05 09:49:01.526978",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Lazertinib",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.521882",
      "occurred_at": "2026-02-05 09:49:01.521882",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "JNJ-61186372",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:01.517995",
      "occurred_at": "2026-02-05 09:49:01.517995",
      "payload": {
        "query_alias": "amivantamab",
        "added_alias": "Amivantamab",
        "assets": [
          5,
          63
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.215376",
      "occurred_at": "2026-02-05 09:49:01.215376",
      "payload": {
        "nct_id": "NCT03767075",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.202517",
      "occurred_at": "2026-02-05 09:49:01.202517",
      "payload": {
        "nct_id": "NCT06816992",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.190023",
      "occurred_at": "2026-02-05 09:49:01.190023",
      "payload": {
        "nct_id": "NCT06632236",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.179171",
      "occurred_at": "2026-02-05 09:49:01.179171",
      "payload": {
        "nct_id": "NCT07062354",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.167343",
      "occurred_at": "2026-02-05 09:49:01.167343",
      "payload": {
        "nct_id": "NCT05117931",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.155786",
      "occurred_at": "2026-02-05 09:49:01.155786",
      "payload": {
        "nct_id": "NCT05299125",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.142642",
      "occurred_at": "2026-02-05 09:49:01.142642",
      "payload": {
        "nct_id": "NCT04988295",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.117588",
      "occurred_at": "2026-02-05 09:49:01.117588",
      "payload": {
        "nct_id": "NCT04077463",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.093590",
      "occurred_at": "2026-02-05 09:49:01.093590",
      "payload": {
        "nct_id": "NCT05845671",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.081804",
      "occurred_at": "2026-02-05 09:49:01.081804",
      "payload": {
        "nct_id": "NCT06385080",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.067443",
      "occurred_at": "2026-02-05 09:49:01.067443",
      "payload": {
        "nct_id": "NCT06667076",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.051843",
      "occurred_at": "2026-02-05 09:49:01.051843",
      "payload": {
        "nct_id": "NCT06750094",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.033727",
      "occurred_at": "2026-02-05 09:49:01.033727",
      "payload": {
        "nct_id": "NCT06120140",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:01.015557",
      "occurred_at": "2026-02-05 09:49:01.015557",
      "payload": {
        "nct_id": "NCT06532032",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.995479",
      "occurred_at": "2026-02-05 09:49:00.995479",
      "payload": {
        "nct_id": "NCT05498428",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.979688",
      "occurred_at": "2026-02-05 09:49:00.979688",
      "payload": {
        "nct_id": "NCT06662786",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.962124",
      "occurred_at": "2026-02-05 09:49:00.962124",
      "payload": {
        "nct_id": "NCT05488314",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.949130",
      "occurred_at": "2026-02-05 09:49:00.949130",
      "payload": {
        "nct_id": "NCT02609776",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.934438",
      "occurred_at": "2026-02-05 09:49:00.934438",
      "payload": {
        "nct_id": "NCT05908734",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.921878",
      "occurred_at": "2026-02-05 09:49:00.921878",
      "payload": {
        "nct_id": "NCT05601973",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.909085",
      "occurred_at": "2026-02-05 09:49:00.909085",
      "payload": {
        "nct_id": "NCT05388669",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.888017",
      "occurred_at": "2026-02-05 09:49:00.888017",
      "payload": {
        "nct_id": "NCT04538664",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.867494",
      "occurred_at": "2026-02-05 09:49:00.867494",
      "payload": {
        "nct_id": "NCT04487080",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.839807",
      "occurred_at": "2026-02-05 09:49:00.839807",
      "payload": {
        "nct_id": "NCT05663866",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.681421",
      "occurred_at": "2026-02-05 09:49:00.681421",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "JNJ-79635322",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.677432",
      "occurred_at": "2026-02-05 09:49:00.677432",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "melphalan",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.673595",
      "occurred_at": "2026-02-05 09:49:00.673595",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "revlimid",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.669558",
      "occurred_at": "2026-02-05 09:49:00.669558",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "velcade",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.665525",
      "occurred_at": "2026-02-05 09:49:00.665525",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Lenalidomide",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.661314",
      "occurred_at": "2026-02-05 09:49:00.661314",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "JNJ-64407564",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.658440",
      "occurred_at": "2026-02-05 09:49:00.658440",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Talquetamab",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.655539",
      "occurred_at": "2026-02-05 09:49:00.655539",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Darzalex",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.651639",
      "occurred_at": "2026-02-05 09:49:00.651639",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "JNJ-54767414",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.647567",
      "occurred_at": "2026-02-05 09:49:00.647567",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Daratumumab",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.643433",
      "occurred_at": "2026-02-05 09:49:00.643433",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Dexamethasone",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.640345",
      "occurred_at": "2026-02-05 09:49:00.640345",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Bortezomib",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.634587",
      "occurred_at": "2026-02-05 09:49:00.634587",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Pomalidomide",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.630130",
      "occurred_at": "2026-02-05 09:49:00.630130",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "JNJ-64007957",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:49:00.626084",
      "occurred_at": "2026-02-05 09:49:00.626084",
      "payload": {
        "query_alias": "teclistamab",
        "added_alias": "Teclistamab",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.323458",
      "occurred_at": "2026-02-05 09:49:00.323458",
      "payload": {
        "nct_id": "NCT06505369",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.310142",
      "occurred_at": "2026-02-05 09:49:00.310142",
      "payload": {
        "nct_id": "NCT06100237",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.297481",
      "occurred_at": "2026-02-05 09:49:00.297481",
      "payload": {
        "nct_id": "NCT06353022",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.282586",
      "occurred_at": "2026-02-05 09:49:00.282586",
      "payload": {
        "nct_id": "NCT05849610",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.269622",
      "occurred_at": "2026-02-05 09:49:00.269622",
      "payload": {
        "nct_id": "NCT05469893",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.248814",
      "occurred_at": "2026-02-05 09:49:00.248814",
      "payload": {
        "nct_id": "NCT07107529",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.237520",
      "occurred_at": "2026-02-05 09:49:00.237520",
      "payload": {
        "nct_id": "NCT06993675",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.226349",
      "occurred_at": "2026-02-05 09:49:00.226349",
      "payload": {
        "nct_id": "NCT05572229",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.214437",
      "occurred_at": "2026-02-05 09:49:00.214437",
      "payload": {
        "nct_id": "NCT06649695",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.203255",
      "occurred_at": "2026-02-05 09:49:00.203255",
      "payload": {
        "nct_id": "NCT07258511",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.191662",
      "occurred_at": "2026-02-05 09:49:00.191662",
      "payload": {
        "nct_id": "NCT05695508",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.178633",
      "occurred_at": "2026-02-05 09:49:00.178633",
      "payload": {
        "nct_id": "NCT07030517",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.167383",
      "occurred_at": "2026-02-05 09:49:00.167383",
      "payload": {
        "nct_id": "NCT05231629",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.145986",
      "occurred_at": "2026-02-05 09:49:00.145986",
      "payload": {
        "nct_id": "NCT07105059",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.133954",
      "occurred_at": "2026-02-05 09:49:00.133954",
      "payload": {
        "nct_id": "NCT04722146",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.120750",
      "occurred_at": "2026-02-05 09:49:00.120750",
      "payload": {
        "nct_id": "NCT03145181",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.108981",
      "occurred_at": "2026-02-05 09:49:00.108981",
      "payload": {
        "nct_id": "NCT05083169",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.095117",
      "occurred_at": "2026-02-05 09:49:00.095117",
      "payload": {
        "nct_id": "NCT05338775",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.083367",
      "occurred_at": "2026-02-05 09:49:00.083367",
      "payload": {
        "nct_id": "NCT04586426",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.071682",
      "occurred_at": "2026-02-05 09:49:00.071682",
      "payload": {
        "nct_id": "NCT05552222",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.056717",
      "occurred_at": "2026-02-05 09:49:00.056717",
      "payload": {
        "nct_id": "NCT06425991",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.045004",
      "occurred_at": "2026-02-05 09:49:00.045004",
      "payload": {
        "nct_id": "NCT04696809",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.033987",
      "occurred_at": "2026-02-05 09:49:00.033987",
      "payload": {
        "nct_id": "NCT04108195",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.020703",
      "occurred_at": "2026-02-05 09:49:00.020703",
      "payload": {
        "nct_id": "NCT05572515",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:49:00.005599",
      "occurred_at": "2026-02-05 09:49:00.005599",
      "payload": {
        "nct_id": "NCT04557098",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.909718",
      "occurred_at": "2026-02-05 09:48:59.909718",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "JNJ-64407564",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.907024",
      "occurred_at": "2026-02-05 09:48:59.907024",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "Talquetamab",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.904435",
      "occurred_at": "2026-02-05 09:48:59.904435",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "Lenalidomide",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.901815",
      "occurred_at": "2026-02-05 09:48:59.901815",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "Fludarabine",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.899146",
      "occurred_at": "2026-02-05 09:48:59.899146",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "Cyclophosphamide",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.896627",
      "occurred_at": "2026-02-05 09:48:59.896627",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "JNJ-68284528",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.894027",
      "occurred_at": "2026-02-05 09:48:59.894027",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "Daratumumab",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.891293",
      "occurred_at": "2026-02-05 09:48:59.891293",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "Dexamethasone",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:59.888275",
      "occurred_at": "2026-02-05 09:48:59.888275",
      "payload": {
        "query_alias": "autoleucel",
        "added_alias": "Bortezomib",
        "assets": [
          55
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:59.570240",
      "occurred_at": "2026-02-05 09:48:59.570240",
      "payload": {
        "nct_id": "NCT05257083",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:59.553089",
      "occurred_at": "2026-02-05 09:48:59.553089",
      "payload": {
        "nct_id": "NCT06577025",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:59.537195",
      "occurred_at": "2026-02-05 09:48:59.537195",
      "payload": {
        "nct_id": "NCT04923893",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:59.521272",
      "occurred_at": "2026-02-05 09:48:59.521272",
      "payload": {
        "nct_id": "NCT06550895",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:59.499205",
      "occurred_at": "2026-02-05 09:48:59.499205",
      "payload": {
        "nct_id": "NCT04133636",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:59.475096",
      "occurred_at": "2026-02-05 09:48:59.475096",
      "payload": {
        "nct_id": "NCT05421663",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:59.463201",
      "occurred_at": "2026-02-05 09:48:59.463201",
      "payload": {
        "nct_id": "NCT04181827",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:57.494953",
      "occurred_at": "2026-02-05 09:48:57.494953",
      "payload": {
        "nct_id": "NCT05243797",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:57.412827",
      "occurred_at": "2026-02-05 09:48:57.412827",
      "payload": {
        "query_alias": "Bleximenib",
        "added_alias": "Azacitidine",
        "assets": [
          9,
          19
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:57.407635",
      "occurred_at": "2026-02-05 09:48:57.407635",
      "payload": {
        "query_alias": "Bleximenib",
        "added_alias": "Venetoclax",
        "assets": [
          9,
          19
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:57.403170",
      "occurred_at": "2026-02-05 09:48:57.403170",
      "payload": {
        "query_alias": "Bleximenib",
        "added_alias": "bleximenib",
        "assets": [
          9,
          19
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:57.400784",
      "occurred_at": "2026-02-05 09:48:57.400784",
      "payload": {
        "query_alias": "Bleximenib",
        "added_alias": "JNJ-75276617",
        "assets": [
          9,
          19
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:57.095155",
      "occurred_at": "2026-02-05 09:48:57.095155",
      "payload": {
        "nct_id": "NCT06852222",
        "linked_assets": 3
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:57.079459",
      "occurred_at": "2026-02-05 09:48:57.079459",
      "payload": {
        "nct_id": "NCT04811560",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:57.066446",
      "occurred_at": "2026-02-05 09:48:57.066446",
      "payload": {
        "nct_id": "NCT05453903",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:57.051477",
      "occurred_at": "2026-02-05 09:48:57.051477",
      "payload": {
        "nct_id": "NCT07295951",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:56.986179",
      "occurred_at": "2026-02-05 09:48:56.986179",
      "payload": {
        "query_alias": "pasritamig",
        "added_alias": "JNJ-78278343",
        "assets": [
          4
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:56.982766",
      "occurred_at": "2026-02-05 09:48:56.982766",
      "payload": {
        "query_alias": "pasritamig",
        "added_alias": "Pasritamig",
        "assets": [
          4
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:56.680417",
      "occurred_at": "2026-02-05 09:48:56.680417",
      "payload": {
        "nct_id": "NCT07164443",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:56.666426",
      "occurred_at": "2026-02-05 09:48:56.666426",
      "payload": {
        "nct_id": "NCT07082920",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:56.653849",
      "occurred_at": "2026-02-05 09:48:56.653849",
      "payload": {
        "nct_id": "NCT07319871",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:56.641783",
      "occurred_at": "2026-02-05 09:48:56.641783",
      "payload": {
        "nct_id": "NCT06095089",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:56.629423",
      "occurred_at": "2026-02-05 09:48:56.629423",
      "payload": {
        "nct_id": "NCT07225946",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:55.163957",
      "occurred_at": "2026-02-05 09:48:55.163957",
      "payload": {
        "query_alias": "RYBREVANT",
        "added_alias": "JNJ-61186372",
        "assets": [
          5
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:55.160867",
      "occurred_at": "2026-02-05 09:48:55.160867",
      "payload": {
        "query_alias": "RYBREVANT",
        "added_alias": "RYBREVANT",
        "assets": [
          5
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:55.158302",
      "occurred_at": "2026-02-05 09:48:55.158302",
      "payload": {
        "query_alias": "RYBREVANT",
        "added_alias": "Amivantamab",
        "assets": [
          5
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:54.855861",
      "occurred_at": "2026-02-05 09:48:54.855861",
      "payload": {
        "nct_id": "NCT07276399",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:54.842026",
      "occurred_at": "2026-02-05 09:48:54.842026",
      "payload": {
        "nct_id": "NCT07227025",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:54.828509",
      "occurred_at": "2026-02-05 09:48:54.828509",
      "payload": {
        "nct_id": "NCT05379595",
        "linked_assets": 2
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:52.690720",
      "occurred_at": "2026-02-05 09:48:52.690720",
      "payload": {
        "query_alias": "SPRAVATO",
        "added_alias": "JNJ-54135419",
        "assets": [
          37
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:52.687109",
      "occurred_at": "2026-02-05 09:48:52.687109",
      "payload": {
        "query_alias": "SPRAVATO",
        "added_alias": "Esketamine",
        "assets": [
          37
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:52.384568",
      "occurred_at": "2026-02-05 09:48:52.384568",
      "payload": {
        "nct_id": "NCT06103760",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:52.013294",
      "occurred_at": "2026-02-05 09:48:52.013294",
      "payload": {
        "nct_id": "NCT07053345",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:49.105552",
      "occurred_at": "2026-02-05 09:48:49.105552",
      "payload": {
        "query_alias": "TECVAYLI",
        "added_alias": "TECVAYLI",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:49.102722",
      "occurred_at": "2026-02-05 09:48:49.102722",
      "payload": {
        "query_alias": "TECVAYLI",
        "added_alias": "Teclistamab",
        "assets": [
          2,
          12
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:48.800080",
      "occurred_at": "2026-02-05 09:48:48.800080",
      "payload": {
        "nct_id": "NCT06477783",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:48.788013",
      "occurred_at": "2026-02-05 09:48:48.788013",
      "payload": {
        "nct_id": "NCT07110844",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:47.313735",
      "occurred_at": "2026-02-05 09:48:47.313735",
      "payload": {
        "query_alias": "TREMFYA",
        "added_alias": "Placebo",
        "assets": [
          24,
          25,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:47.310703",
      "occurred_at": "2026-02-05 09:48:47.310703",
      "payload": {
        "query_alias": "TREMFYA",
        "added_alias": "CNTO1959",
        "assets": [
          24,
          25,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:47.306528",
      "occurred_at": "2026-02-05 09:48:47.306528",
      "payload": {
        "query_alias": "TREMFYA",
        "added_alias": "Tremfya",
        "assets": [
          24,
          25,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:47.303642",
      "occurred_at": "2026-02-05 09:48:47.303642",
      "payload": {
        "query_alias": "TREMFYA",
        "added_alias": "Guselkumab",
        "assets": [
          24,
          25,
          59
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:47.000804",
      "occurred_at": "2026-02-05 09:48:47.000804",
      "payload": {
        "nct_id": "NCT05858632",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.990304",
      "occurred_at": "2026-02-05 09:48:46.990304",
      "payload": {
        "nct_id": "NCT04645355",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.979800",
      "occurred_at": "2026-02-05 09:48:46.979800",
      "payload": {
        "nct_id": "NCT06563323",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.968893",
      "occurred_at": "2026-02-05 09:48:46.968893",
      "payload": {
        "nct_id": "NCT06586281",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.958389",
      "occurred_at": "2026-02-05 09:48:46.958389",
      "payload": {
        "nct_id": "NCT05004727",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.946407",
      "occurred_at": "2026-02-05 09:48:46.946407",
      "payload": {
        "nct_id": "NCT05669833",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.925759",
      "occurred_at": "2026-02-05 09:48:46.925759",
      "payload": {
        "nct_id": "NCT06651489",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.915364",
      "occurred_at": "2026-02-05 09:48:46.915364",
      "payload": {
        "nct_id": "NCT04929210",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.901047",
      "occurred_at": "2026-02-05 09:48:46.901047",
      "payload": {
        "nct_id": "NCT05049798",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.879688",
      "occurred_at": "2026-02-05 09:48:46.879688",
      "payload": {
        "nct_id": "NCT06663332",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.868224",
      "occurred_at": "2026-02-05 09:48:46.868224",
      "payload": {
        "nct_id": "NCT05347095",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.855399",
      "occurred_at": "2026-02-05 09:48:46.855399",
      "payload": {
        "nct_id": "NCT07141004",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.844633",
      "occurred_at": "2026-02-05 09:48:46.844633",
      "payload": {
        "nct_id": "NCT06408935",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.831883",
      "occurred_at": "2026-02-05 09:48:46.831883",
      "payload": {
        "nct_id": "NCT03451851",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.805094",
      "occurred_at": "2026-02-05 09:48:46.805094",
      "payload": {
        "nct_id": "NCT04882098",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.786367",
      "occurred_at": "2026-02-05 09:48:46.786367",
      "payload": {
        "nct_id": "NCT04936308",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:46.628908",
      "occurred_at": "2026-02-05 09:48:46.628908",
      "payload": {
        "query_alias": "STELARA",
        "added_alias": "Placebo",
        "assets": [
          24,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:46.626054",
      "occurred_at": "2026-02-05 09:48:46.626054",
      "payload": {
        "query_alias": "STELARA",
        "added_alias": "TREMFYA",
        "assets": [
          24,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:46.622918",
      "occurred_at": "2026-02-05 09:48:46.622918",
      "payload": {
        "query_alias": "STELARA",
        "added_alias": "STELARA",
        "assets": [
          24,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:46.620949",
      "occurred_at": "2026-02-05 09:48:46.620949",
      "payload": {
        "query_alias": "STELARA",
        "added_alias": "Ustekinumab",
        "assets": [
          24,
          59
        ]
      }
    },
    {
      "event_type": "trial_alias_bootstrapped",
      "created_at": "2026-02-05 09:48:46.618688",
      "occurred_at": "2026-02-05 09:48:46.618688",
      "payload": {
        "query_alias": "STELARA",
        "added_alias": "Guselkumab",
        "assets": [
          24,
          59
        ]
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.314271",
      "occurred_at": "2026-02-05 09:48:46.314271",
      "payload": {
        "nct_id": "NCT04496063",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.303219",
      "occurred_at": "2026-02-05 09:48:46.303219",
      "payload": {
        "nct_id": "NCT05387031",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.283115",
      "occurred_at": "2026-02-05 09:48:46.283115",
      "payload": {
        "nct_id": "NCT02103361",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.271451",
      "occurred_at": "2026-02-05 09:48:46.271451",
      "payload": {
        "nct_id": "NCT05299931",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.260243",
      "occurred_at": "2026-02-05 09:48:46.260243",
      "payload": {
        "nct_id": "NCT03941132",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.248152",
      "occurred_at": "2026-02-05 09:48:46.248152",
      "payload": {
        "nct_id": "NCT06807593",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.237216",
      "occurred_at": "2026-02-05 09:48:46.237216",
      "payload": {
        "nct_id": "NCT05083182",
        "linked_assets": 1
      }
    },
    {
      "event_type": "trial_assets_linked",
      "created_at": "2026-02-05 09:48:46.225042",
      "occurred_at": "2026-02-05 09:48:46.225042",
      "payload": {
        "nct_id": "NCT07303686",
        "linked_assets": 1
      }
    }
  ],
  "trials": [
    {
      "nct_id": "NCT04083976",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-04",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04119050",
      "overall_status": "RECRUITING",
      "phase": "PHASE2,PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "Gravis"
      ]
    },
    {
      "nct_id": "NCT04538664",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "RYBREVANT",
        "amivantamab"
      ]
    },
    {
      "nct_id": "NCT05663866",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "RYBREVANT",
        "amivantamab",
        "autoleucel"
      ]
    },
    {
      "nct_id": "NCT04487080",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "Gravis",
        "RYBREVANT",
        "amivantamab"
      ]
    },
    {
      "nct_id": "NCT04181827",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "TALVEY + TECVAYLI"
      ]
    },
    {
      "nct_id": "NCT04882098",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "Gravis"
      ]
    },
    {
      "nct_id": "NCT04936308",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "Gravis"
      ]
    },
    {
      "nct_id": "NCT04325828",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "ERLEADA"
      ]
    },
    {
      "nct_id": "NCT04108208",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE4",
      "last_update_posted": "2026-02-04",
      "linked_assets": [
        "ERLEADA",
        "Gravis"
      ]
    },
    {
      "nct_id": "NCT04113018",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-03",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06066346",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-02-03",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05388669",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "RYBREVANT",
        "amivantamab"
      ]
    },
    {
      "nct_id": "NCT03390504",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03462719",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03901963",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06266663",
      "overall_status": "RECRUITING",
      "phase": null,
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03596645",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03451851",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "Gravis"
      ]
    },
    {
      "nct_id": "NCT04033445",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2,PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT03466411",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2,PHASE3",
      "last_update_posted": "2026-02-02",
      "linked_assets": [
        "STELARA",
        "TREMFYA"
      ]
    },
    {
      "nct_id": "NCT03301220",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-30",
      "linked_assets": []
    },
    {
      "nct_id": "NCT02365597",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-30",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03881098",
      "overall_status": "RECRUITING",
      "phase": "NA",
      "last_update_posted": "2026-01-29",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06319820",
      "overall_status": "RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-27",
      "linked_assets": [
        "INLEXZO"
      ]
    },
    {
      "nct_id": "NCT04557098",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-27",
      "linked_assets": [
        "TALVEY + TECVAYLI"
      ]
    },
    {
      "nct_id": "NCT05421663",
      "overall_status": "RECRUITING",
      "phase": "PHASE1,PHASE2",
      "last_update_posted": "2026-01-27",
      "linked_assets": [
        "JNJ-1900"
      ]
    },
    {
      "nct_id": "NCT05289687",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-26",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06193863",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-23",
      "linked_assets": []
    },
    {
      "nct_id": "NCT07245394",
      "overall_status": "RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-23",
      "linked_assets": [
        "Gravis"
      ]
    },
    {
      "nct_id": "NCT05316155",
      "overall_status": "RECRUITING",
      "phase": "PHASE1,PHASE2",
      "last_update_posted": "2026-01-22",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05601973",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-21",
      "linked_assets": [
        "amivantamab"
      ]
    },
    {
      "nct_id": "NCT05900388",
      "overall_status": "NOT_YET_RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-21",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04933539",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-20",
      "linked_assets": []
    },
    {
      "nct_id": "NCT03652064",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-20",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06220604",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-20",
      "linked_assets": []
    },
    {
      "nct_id": "NCT04267887",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-20",
      "linked_assets": [
        "ERLEADA"
      ]
    },
    {
      "nct_id": "NCT05972135",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-20",
      "linked_assets": [
        "TALVEY + TECVAYLI",
        "TECVAYLI"
      ]
    },
    {
      "nct_id": "NCT06211764",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-16",
      "linked_assets": [
        "INLEXZO"
      ]
    },
    {
      "nct_id": "NCT04658862",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-16",
      "linked_assets": [
        "INLEXZO"
      ]
    },
    {
      "nct_id": "NCT04640623",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT07194070",
      "overall_status": "RECRUITING",
      "phase": null,
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT02354014",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06768489",
      "overall_status": "RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06604715",
      "overall_status": "RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05652335",
      "overall_status": "RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05455320",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT07266441",
      "overall_status": "NOT_YET_RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT05050097",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    },
    {
      "nct_id": "NCT06500884",
      "overall_status": "RECRUITING",
      "phase": "PHASE2",
      "last_update_posted": "2026-01-16",
      "linked_assets": []
    }
  ]
}